Target intelligence / Profile preview

Opioid Receptor Delta 1 (OPRD1)

Target
OPRD1
Molecular classification
G protein-coupled receptor, GPCR, Rhodopsin family receptor
01

Overview

OPRD1 encodes a G protein-coupled receptor that binds endogenous enkephalins and other opioids. It plays a key role in pain modulation, potentially influencing insulin secretion, and is implicated in diseases such as pain syndromes, irritable bowel syndrome, and metabolic disorders like type 2 diabetes. Selective activation or inhibition holds therapeutic potential, with careful consideration required for safety concerns like respiratory depression and seizure risk.

Other names
Delta-type opioid receptorDORDOPDOR-1D-OR-1
02

Mechanism of action

Upon ligand binding, activates G proteins, leading to inhibition of adenylate cyclase activity, decreased calcium ion currents, and increased potassium ion conductance.

03

Biological functions

G protein-coupled opioid receptor signaling pathwayCellular response to hypoxiaPositive regulation of peptidyl-serine phosphorylationAnalgesia modulationRegulation of insulin secretionModulation of neurotransmitter release
04

Disease associations

Pain syndromesIrritable bowel syndromeBowel habit changeAdiposity riskHyperglycemiaType 2 diabetes
05

Safety considerations

Respiratory depression (high doses)Seizure risk (high doses of some agonists)Development of tolerance
06

Interacting drugs

Enkephalins

3 more in the full profile.

Beyond the preview

Go deeper on Opioid Receptor Delta 1 (OPRD1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Opioid Receptor Delta 1 (OPRD1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call